Phase
Condition
Prostate Cancer
Prostate Cancer, Early, Recurrent
Urologic Cancer
Treatment
Preventive administration of Rapaflo
Standard Care
Clinical Study ID
Ages > 18 Male
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Adult male 18 years of age or older
Patients with confirmed diagnosis of adenocarcinoma of the prostate.
The primary treatment should be external beam radiation therapy (EBRT) with orwithout high dose rate (HDR) brachytherapy boost.
Clinical or radiological diagnosis of T1a - T3b.
No limitation with respect to Gleason score.
No limitation with respect to total Prostate-specific Antigen (PSA) value.
Karnofsky performance score (KPS) of ≥ 70.
Exclusion
Exclusion Criteria:
Small cell cancer of the prostate
T4 disease, invading bladder or rectum.
Adjuvant or salvage radiation therapy
Brachy monotherapy
KPS < 70
Study Design
Study Description
Connect with a study center
Centre Hospitalier des Vallées de l'Outaouais, Hôpital de Gatineau
Gatineau, Quebec J8P 7H2
CanadaSite Not Available
Hôpital Charles-Lemoyne
Greenfield Park, Quebec J4V 2H1
CanadaSite Not Available
Hôpital de la Cité-de-la-santé de Laval
Laval, Quebec H7M 3L9
CanadaSite Not Available
Jewish General Hospital, McGill University
Montréal, Quebec H3T 1E2
CanadaSite Not Available
CHUQ, L'Hôtel-Dieu de Québec
Québec, Quebec G1R 2J6
CanadaSite Not Available
Centre de santé Rimouski-Neigette
Rimouski, Quebec G5L 5T1
CanadaSite Not Available
CHUS - Hôpital Fleurimont
Sherbrooke, Quebec J1H 5N4
CanadaSite Not Available
Centre Hospitalier régional de Trois-Rivières
Trois-Rivières, Quebec G8Z 3R9
CanadaSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.